Two-Year Outcomes of Treat-and-Extend Intravitreal Aflibercept for Exudative Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

Two-Year Outcomes of Treat-and-Extend Intravitreal Aflibercept for Exudative Age-Related Macular Degeneration

Published:2020-08 Issue:8 Volume:4 Page:767-776
ISSN:2468-6530
Container-title:Ophthalmology Retina
language:en
Short-container-title:Ophthalmology Retina

Author:

Maruko Ichiro^ORCID,Ogasawara Masashi,Yamamoto Akiko,Itagaki Kanako^ORCID,Hasegawa Taiji^ORCID,Arakawa Hisaya,Nakayama Makiko,Koizumi Hideki,Okada Annabelle A.,Sekiryu Tetsuju^ORCID,Iida Tomohiro

Publisher

Elsevier BV

Subject

Ophthalmology

Reference41 articles.

1. Report on the nation-wide epidemiological survey of exudative age-related macular degeneration in Japan;Yuzawa;Int Ophthalmol,1997

2. The 5-year incidence and risk factors for age-related maculopathy in a general Japanese population: the Hisayama Study;Miyazaki;Invest Ophthalmol Vis Sci,2005

3. Nine-year incidence and risk factors for age-related macular degeneration in a defined Japanese population: the Hisayama Study;Yasuda;Ophthalmology,2009

4. Prevalence and genetic characteristics of geographic atrophy among elderly Japanese with age-related macular degeneration;Sakurada;PLoS One,2016

5. Clinical characteristics of exudative age-related macular degeneration in Japanese patients;Maruko;Am J Ophthalmol,2007

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switch to faricimab after initial treatment with aflibercept in eyes with neovascular age-related macular degeneration;International Ophthalmology;2024-09-05

2. Retinal and choroidal changes after anti-VEGF therapy in neovascular-AMD patients: A systematic review and meta-analysis of SD-OCT studies;Survey of Ophthalmology;2024-07

3. Retinal and choroidal efficacy of switching treatment to faricimab in recalcitrant neovascular age related macular degeneration;Scientific Reports;2024-04-26

4. The Reinforced Treat-and-Extend Protocol for Exudative Age-Related Macular Degeneration: Retrospective Assessment of 24-Month Real-World Outcomes in France;Ophthalmology and Therapy;2024-04-16

5. Factors Associated with Success of Switching to Faricimab for Neovascular Age-Related Macular Degeneration Refractory to Intravitreal Aflibercept;Life;2024-04-04